[go: up one dir, main page]

YU36514B - Process for obtaining thienylphenyl o-(aminoalkyl)ketone oximes and furyl-phenyl o-(aminalkyl)ketone oximes - Google Patents

Process for obtaining thienylphenyl o-(aminoalkyl)ketone oximes and furyl-phenyl o-(aminalkyl)ketone oximes

Info

Publication number
YU36514B
YU36514B YU02777/74A YU277774A YU36514B YU 36514 B YU36514 B YU 36514B YU 02777/74 A YU02777/74 A YU 02777/74A YU 277774 A YU277774 A YU 277774A YU 36514 B YU36514 B YU 36514B
Authority
YU
Yugoslavia
Prior art keywords
ketone oximes
aminalkyl
thienylphenyl
aminoalkyl
furyl
Prior art date
Application number
YU02777/74A
Other languages
English (en)
Other versions
YU277774A (en
Inventor
Thuillier Germanine
Germanine Thuillier
Vincennes Laborest Jacqueline
Laborest Jacqueline Vincennes
Bessing Pierro
Pierro Bessing
Original Assignee
Rolland Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolland Sa A filed Critical Rolland Sa A
Publication of YU277774A publication Critical patent/YU277774A/xx
Publication of YU36514B publication Critical patent/YU36514B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70Nitro radicals
    • C07D307/71Nitro radicals attached in position 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
YU02777/74A 1973-10-19 1974-10-17 Process for obtaining thienylphenyl o-(aminoalkyl)ketone oximes and furyl-phenyl o-(aminalkyl)ketone oximes YU36514B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7337444A FR2248033B1 (pl) 1973-10-19 1973-10-19

Publications (2)

Publication Number Publication Date
YU277774A YU277774A (en) 1982-02-25
YU36514B true YU36514B (en) 1984-02-29

Family

ID=9126699

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02777/74A YU36514B (en) 1973-10-19 1974-10-17 Process for obtaining thienylphenyl o-(aminoalkyl)ketone oximes and furyl-phenyl o-(aminalkyl)ketone oximes

Country Status (19)

Country Link
US (1) US4029808A (pl)
JP (3) JPS50111064A (pl)
AT (1) AT339890B (pl)
BE (1) BE821237A (pl)
CA (1) CA1064491A (pl)
CH (1) CH601279A5 (pl)
CS (1) CS192537B2 (pl)
DD (1) DD115118A5 (pl)
DE (2) DE2463088C1 (pl)
FR (1) FR2248033B1 (pl)
GB (1) GB1436307A (pl)
HU (1) HU170388B (pl)
IL (1) IL45772A (pl)
NL (1) NL7412659A (pl)
OA (1) OA04796A (pl)
PH (1) PH12992A (pl)
PL (1) PL99875B1 (pl)
YU (1) YU36514B (pl)
ZA (1) ZA746631B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207319A (en) * 1973-10-19 1980-06-10 Albert Rolland S.A. Thienyl or furyl phenyl O-hetero amino alkyl oximes and use thereof
US4148911A (en) * 1977-07-08 1979-04-10 Societe Anonyme Dite Albert Rolland S.A. Method of treating respiratory disorders
FR2428036A1 (fr) * 1978-06-08 1980-01-04 Rolland Sa A Nouveaux intermediaires de synthese pour la preparation de 0-(amino alkyl) oximes diaromatiques
US4246277A (en) * 1979-06-22 1981-01-20 Albert Rolland S.A. Lowering the concentration of plasma triglycerides
FR2480752A1 (fr) * 1980-04-21 1981-10-23 Cherqui Jean Nouveaux composes derives de la phenylthiazolylcetone, leur procede d'obtention et les compositions pharmaceutiques en contenant
JPS56174550U (pl) * 1980-05-27 1981-12-23
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
WO1995026956A1 (fr) * 1994-04-01 1995-10-12 Shionogi & Co., Ltd. Derive d'oxime et bactericide le contenant en tant qu'ingredient actif
US6268312B1 (en) * 1994-04-01 2001-07-31 Shionogi & Co., Ltd. Oxime derivative and bactericide containing the same as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3084171A (en) * 1961-10-19 1963-04-02 Abbott Lab 5-nitro-2-furylamidine and alkyl 5-nitro-2-furylimidate
US3272833A (en) * 1963-10-09 1966-09-13 Abbott Lab Certain substituted 5-nitro-2-furylamidoximes
NL6810133A (pl) * 1968-07-18 1970-01-20
US3895039A (en) * 1972-11-06 1975-07-15 Roussel Uclaf Carbamaldoximes

Also Published As

Publication number Publication date
AT339890B (de) 1977-11-10
HU170388B (pl) 1977-06-28
FR2248033A1 (pl) 1975-05-16
US4029808A (en) 1977-06-14
DD115118A5 (pl) 1975-09-12
JPS5538946B2 (pl) 1980-10-07
PH12992A (en) 1979-10-29
JPS5325555A (en) 1978-03-09
DE2463088C1 (de) 1982-07-15
IL45772A0 (en) 1974-12-31
FR2248033B1 (pl) 1977-03-11
DE2449205A1 (de) 1975-04-24
OA04796A (fr) 1980-08-31
CH601279A5 (pl) 1978-06-30
JPS50111064A (en) 1975-09-01
AU7415574A (en) 1976-04-15
JPS5373556A (en) 1978-06-30
BE821237A (fr) 1975-02-17
GB1436307A (en) 1976-05-19
PL99875B1 (pl) 1978-08-31
CS192537B2 (en) 1979-08-31
NL7412659A (nl) 1975-04-22
IL45772A (en) 1978-04-30
ZA746631B (en) 1976-02-25
DE2449205C2 (de) 1982-03-11
YU277774A (en) 1982-02-25
ATA829274A (de) 1977-03-15
CA1064491A (en) 1979-10-16

Similar Documents

Publication Publication Date Title
GB1535226A (en) Oximes
ZA745372B (en) Chemical process
IL44331A0 (en) Printing apparatus and method
ZA755984B (en) Oxime
ZA756124B (en) Packaging apparatus and process
YU324080A (en) Process for obtaining 14 beta-alkyloxamorphinane
HK50778A (en) Material exchange process and apparatus
YU36514B (en) Process for obtaining thienylphenyl o-(aminoalkyl)ketone oximes and furyl-phenyl o-(aminalkyl)ketone oximes
IL50168A (en) Lid and process for its production
HU173786B (hu) Sposob poluchenija novykh 6,11-digidro-5h-pirido/2,3-b//1,5/ benzodiazepin-5-onov i 5,11-digidro-6h-pirido/2,3-b//1,4/ benzodiazepin-6-onov
YU97176A (en) Process for obtaining ketone derivatives
IL44279A0 (en) N-phenylpyrroles and process for their manufacture
GB1507728A (en) Dry process imaging method
CA953478A (en) Foundry coremaking process and apparatus
IL44529A0 (en) Separation process
IL48043A0 (en) Omega-nor-cycloalkyl-13,14-dehydroprostaglandins and process for their preparation
CA1015996A (en) Pinning method and apparatus
GB1515864A (en) 17alpha-hydroxy-delta1,3,5(10),15-oestratetraenes and process for their manufacture
JPS5227740A (en) Process for preparing 3*55 diisubstitutedd44 hydroxybenzaldehyde
ZA74158B (en) Chemical process
EG11394A (en) Process and apparatus for electrolysis
EG11686A (en) Improved regeneration process and apparatus
JPS5243576A (en) Process container
IL48930A0 (en) Vulcanisation process
ZA742796B (en) Freeze-branding process and apparatus